24,351 Shares in Centene Corporation $CNC Acquired by Leonteq Securities AG

Posted by Brenda Bartman on May 22nd, 2026

Leonteq Securities AG bought a new position in shares of Centene Corporation (NYSE:CNC – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 24,351 shares of the company’s stock, valued at approximately $1,002,000.

Several other hedge funds have also added to or reduced their stakes in CNC. Baird Financial Group Inc. acquired a new stake in Centene during the 1st quarter worth approximately $236,000. Sivia Capital Partners LLC raised its holdings in Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after purchasing an additional 4,315 shares during the last quarter. CW Advisors LLC raised its holdings in Centene by 20.3% during the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after purchasing an additional 820 shares during the last quarter. NewEdge Advisors LLC raised its holdings in Centene by 6.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after purchasing an additional 2,582 shares during the last quarter. Finally, Treasurer of the State of North Carolina raised its holdings in Centene by 0.4% during the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock worth $12,590,000 after purchasing an additional 967 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Performance

Shares of CNC stock opened at $57.72 on Friday. The firm has a market capitalization of $28.50 billion, a PE ratio of -4.39, a price-to-earnings-growth ratio of 1.13 and a beta of 1.06. The firm has a fifty day simple moving average of $42.60 and a two-hundred day simple moving average of $41.51. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.76. Centene Corporation has a 12 month low of $25.08 and a 12 month high of $60.76.

Centene (NYSE:CNC – Get Free Report) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $3.37 EPS for the quarter, beating analysts’ consensus estimates of $2.23 by $1.14. The business had revenue of $49.94 billion during the quarter, compared to analyst estimates of $47.53 billion. Centene had a negative net margin of 3.25% and a positive return on equity of 5.57%. Centene’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.90 EPS. Analysts forecast that Centene Corporation will post 3.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the stock. Oppenheimer restated an “outperform” rating and set a $58.00 price target (up from $45.00) on shares of Centene in a report on Wednesday, April 29th. Weiss Ratings reiterated a “sell (d)” rating on shares of Centene in a research note on Monday, April 20th. Robert W. Baird lifted their price objective on shares of Centene from $36.00 to $37.00 and gave the company a “neutral” rating in a research note on Wednesday, April 15th. Raymond James Financial set a $60.00 price objective on shares of Centene in a research note on Wednesday, April 29th. Finally, Wells Fargo & Company lifted their price objective on shares of Centene from $44.00 to $56.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Centene has an average rating of “Hold” and an average target price of $56.59.

Read Our Latest Research Report on Centene

Centene Company Profile

(Free Report)

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.